These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33550359)

  • 1. [Clinical analysis of 61 patients with thrombotic thrombocytopenic purpura].
    Shi MJ; Gao WB; Huang WF; Zhu JH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Sep; 53(1):210-214. PubMed ID: 33550359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
    Li A; Khalighi PR; Wu Q; Garcia DA
    J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics of 83 patients with thrombotic thrombocytopenic purpura].
    Wang XY; Liu XF; Xue F; Liu W; Chen YF; Huang YT; Fu RF; Zhang L; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):216-221. PubMed ID: 32311891
    [No Abstract]   [Full Text] [Related]  

  • 4. A modified PLASMIC score including the lactate dehydrogenase/the upper limit of normal ratio more accurately identifies Chinese thrombotic thrombocytopenic purpura patients than the original PLASMIC score.
    Zhao N; Zhou L; Hu X; Sun G; Chen C; Fan X; Zhou S; Tao X; Liu H; Zheng C
    J Clin Apher; 2020 Apr; 35(2):79-85. PubMed ID: 31724781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
    Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura.
    Rick ME; Austin H; Leitman SF; Krizek DM; Aronson DL
    Am J Hematol; 2004 Feb; 75(2):96-100. PubMed ID: 14755376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Solenthaler M; Lämmle B
    Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets: thrombotic thrombocytopenic purpura.
    George JN; Sadler JE; Lämmle B
    Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.
    Liu A; Dhaliwal N; Upreti H; Kasmani J; Dane K; Moliterno A; Braunstein E; Brodsky R; Chaturvedi S
    Transfusion; 2021 Jan; 61(1):266-273. PubMed ID: 33179792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 14 patients with thrombotic thrombocytopenic purpura].
    Wang Y; Zhang JY; Niu ZY; Lin FR; Zhou JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):407-11. PubMed ID: 24763014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
    Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
    Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
    Scully M; Cataland SR; Peyvandi F; Coppo P; Knöbl P; Kremer Hovinga JA; Metjian A; de la Rubia J; Pavenski K; Callewaert F; Biswas D; De Winter H; Zeldin RK;
    N Engl J Med; 2019 Jan; 380(4):335-346. PubMed ID: 30625070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of thrombotic thrombocytopenic purpura in two French centers: A series of 27 patients].
    Deroux A; Sirodot M; Daguindau N; Barro C; Coppo P; Bouillet L
    Rev Med Interne; 2016 Jan; 37(1):13-8. PubMed ID: 26065327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura.
    Reeves HM; Maitta RW
    Thromb Res; 2022 Jul; 215():30-36. PubMed ID: 35617796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura].
    Hulstein JJ; Rison CN; Kappers-Klunne MC; Hene RJ; Franx A; de Groot PG; Brand A; Fijnheer R
    Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1972-6. PubMed ID: 15524133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Moake JL
    Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombotic thrombocytopenic purpura - a rare diagnosis].
    Einarsdottir S; Rosander C; Frändberg S; Dezfoolian H; Lisak M
    Lakartidningen; 2023 Sep; 120():. PubMed ID: 37712566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
    Yagi H
    Rinsho Byori; 2005 Jul; 53(7):630-8. PubMed ID: 16104532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of thrombotic thrombocytopenic purpura].
    Galstyan GM; Klebanova EE
    Ter Arkh; 2020 Dec; 92(12):207-217. PubMed ID: 33720596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.